New diagnostic index for prediction of severe irAEs in patients with metastatic melanoma taking checkpoint inhibitors.

被引：0
|
作者：
Zhukova, Natalia V.
Orlova, Rashida
Malkova, Anna
Kaledina, Ekaterina
Demchenkova, Alexandra
Naymushina, Polina
Nazarov, V.
Mazing, A.
Lapin, S.
Beliak, Natalia P.
Shoenfeld, Y.
机构：
[1] St Petersburg State Univ, Fac Med, St Petersburg, Russia
[2] St Petersburg State Univ, St Petersburg, Russia
[3] SPb SBIH, City Clin Oncol Dispensary, St Petersburg, Russia
[4] Pavlov First St Petersburg State Med Univ, St Petersburg, Russia
[5] Ariel Univ, Ariel, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21565
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The experience of immune checkpoint inhibitors in Chinese patients with metastatic melanoma: a retrospective case series
    Wen, Xizhi
    Ding, Ya
    Li, Jingjing
    Zhao, Jingjing
    Peng, Ruiqing
    Li, Dandan
    Zhu, Baoyan
    Wang, Yao
    Zhang, Xing
    Zhang, Xiaoshi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (09) : 1153 - 1162
  • [42] Immune and metabolic architecture of TIME in metastatic acral melanoma patients treated with checkpoint inhibitors
    Ekmekcioglu, Suhendan
    Ludford, Kaysia
    Cho, SungNam
    Eddine-Bentebibel, Salah
    Basi, Akshay V.
    Abdel-Wahab, Reham
    Wani, Khalida M.
    Abdel-Wahab, Noha
    Burks, Jared K.
    Diab, Adi
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [43] Impact of clinicopathological characteristics on survival in patients treated with immune checkpoint inhibitors for metastatic melanoma
    Zhao, Bin
    Zhao, Hong
    Zhao, Jiaxin
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (01) : 169 - 177
  • [44] The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors
    Julia Lai-Kwon
    Chloe Khoo
    Serigne Lo
    Donna Milne
    Mustafa Mohamed
    Jeanette Raleigh
    Kortnye Smith
    Karolina Lisy
    Shahneen Sandhu
    Michael Jefford
    Journal of Cancer Survivorship, 2019, 13 : 503 - 511
  • [45] The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors
    Lai-Kwon, Julia
    Khoo, Chloe
    Lo, Serigne
    Milne, Donna
    Mohamed, Mustafa
    Raleigh, Jeanette
    Smith, Kortnye
    Lisy, Karolina
    Sandhu, Shahneen
    Jefford, Michael
    JOURNAL OF CANCER SURVIVORSHIP, 2019, 13 (04) : 503 - 511
  • [46] Bevacizumab for radiation necrosis of the brain or steroid-refractory edema in patients with melanoma receiving immune checkpoint inhibitors.
    Lopetegui-Lia, Nerea
    Dima, Danai
    Osantowski, Bennett
    Davis, Robin
    Song, Jung Min
    McNamara, Michael J.
    Suh, John H.
    Chao, Samuel T.
    Funchain, Pauline
    Kennedy, Lucy Boyce
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Clinical benefit and toxicity of nivolumab plus ipilimumab in patients with advanced melanoma previously treated with checkpoint blockade inhibitors.
    Friedman, Claire Frances
    Wolchok, Jedd D.
    Postow, Michael Andrew
    Shoushtari, Alexander Noor
    Callahan, Margaret K.
    Momtaz, Parisa
    Chapman, Paul B.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [48] A single-institution experience of pneumonitis in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
    Masur, Jack
    Ali, Soham
    Fortune, Kathryn
    Bueno, Juliana
    Battey, Thomas
    Mullapudi, Abhishek
    Goudarzi, Ariaz
    Patel, Hitesh
    Sturek, Jeffrey
    Devitt, Michael Edward
    Skelton, William Paul
    Dreicer, Robert
    Viscuse, Paul Vincent
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [49] Disparity in initiation of checkpoint inhibitors among commercially insured and Medicare Advantage patients with metastatic melanoma
    Li, Meng
    Liao, Kaiping
    Nowakowska, Malgorzata
    Wehner, Mackenzie
    Shih, Ya-Chen Tina
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (11): : 1232 - 1241
  • [50] Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists
    Kakavand, Hojabr
    Wilmott, James S.
    Long, Georgina V.
    Scolyer, Richard A.
    PATHOLOGY, 2016, 48 (02) : 194 - 202
12345